Surgepays is trading at $0.26 (-7.84%) after its August 14, 2026, Q2 earnings release.

  • Returned to profitability with $1.29 million in net income and $0.05 EPS.
  • Revenue rose 40.7% year over year to $16.20 million.
  • Shares had already gained 14.36% during regular trading, suggesting after-hours activity followed a sharp volatile session.